Related Experiment Video
Updated: Nov 9, 2025

Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome
Published on: July 5, 2024
Obesity alters the ovarian proteomic response to zearalenone exposure†
M Estefanía González-Alvarez1, Bailey C McGuire1, Aileen F Keating1
1Department of Animal Science and Interdepartmental Toxicology Graduate Program, Iowa State University, Ames IA, USA.
Abstract:
Zearalenone (ZEN), a nonsteroidal estrogenic mycotoxin, is detrimental to female reproduction. Altered chemical biotransformation, depleted primordial follicles and a blunted genotoxicant response have been discovered in obese female ovaries, thus, this study investigated the hypothesis that obesity would enhance ovarian sensitivity to ZEN exposure. Seven-week-old female wild-type nonagouti KK.Cg-a/a mice (lean) and agouti lethal yellow KK.Cg-Ay/J mice (obese) received food and water ad libitum, and either saline or ZEN (40 μg/kg) per os for 15 days. Body and organ weights, and estrous cyclicity were recorded, and ovaries collected posteuthanasia for protein analysis. Body and liver weights were increased (P < 0.05) in the obese mice, but obesity did not affect (P > 0.05) heart, kidney, spleen, uterus, or ovary weight and there was no impact (P > 0.05) of ZEN exposure on body or organ weight in lean or obese mice. Obese mice had shorter proestrus (P < 0.05) and a tendency (P = 0.055) for longer metestrus/diestrus. ZEN exposure in obese mice increased estrus but shortened metestrus/diestrus length. Neither obesity nor ZEN exposure impacted (P > 0.05) circulating progesterone, or ovarian abundance of EPHX1, GSTP1, CYP2E1, ATM, BRCA1, DNMT1, HDAC1, H4K16ac, or H3K9me3. Lean mice exposed to ZEN had a minor increase in γH2AX abundance (P < 0.05). In lean and obese mice, LC-MS/MS identified alterations to proteins involved in chemical metabolism, DNA repair and reproduction. These data identify ZEN-induced adverse ovarian modes of action and suggest that obesity is additive to ZEN-induced ovotoxicity.
Insights
Obesity enhances ovarian sensitivity to zearalenone (ZEN), a mycotoxin detrimental to female reproduction. This study suggests obesity adds to ZEN-induced ovotoxicity, impacting reproductive cycles and protein alterations.
Area of Science:
- Reproductive Toxicology
- Environmental Health
- Endocrinology
Background:
- Zearalenone (ZEN) is a mycotoxin impacting female reproduction.
- Obesity is linked to altered ovarian function and chemical biotransformation.
- The interaction between obesity and ZEN's ovarian effects requires investigation.
Purpose of the Study:
- To investigate if obesity enhances ovarian sensitivity to ZEN exposure.
- To determine the impact of obesity and ZEN on reproductive parameters and ovarian protein profiles.
- To elucidate ZEN-induced adverse ovarian modes of action in the context of obesity.
Main Methods:
- Female mice, lean (KK.Cg-a/a) and obese (KK.Cg-Ay/J), were administered saline or ZEN (40 μg/kg) orally for 15 days.
- Body weight, organ weights, and estrous cyclicity were monitored.
- Ovarian protein analysis using LC-MS/MS was performed post-euthanasia.
Main Results:
- Obese mice exhibited increased body and liver weights.
- ZEN exposure in obese mice altered estrous cyclicity (increased estrus, shortened metestrus/diestrus).
- LC-MS/MS revealed alterations in proteins related to chemical metabolism, DNA repair, and reproduction in both lean and obese mice exposed to ZEN.
Conclusions:
- Obesity appears to exacerbate ZEN-induced ovotoxicity.
- ZEN exposure, particularly in obese mice, affects reproductive cyclicity.
- The study identifies specific protein alterations indicative of ZEN's adverse effects on ovarian function, influenced by obesity.
Related Concept Videos
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Oogenesis
Obesity
Hormonal Control of the Ovarian Cycle
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Drug Dosing: Obese Patients

